<DOC>
	<DOCNO>NCT03072394</DOCNO>
	<brief_summary>A randomized clinical trial test efficacy EMLA cream ( lidocaine 2.5 % prilocaine 2.5 % ratio 1:1 weight ) comparison establish local anesthesia ( LA ) protocol lidocaine subcutaneous injection , provide adequate peri-operative local anesthesia transradial coronary angiography .</brief_summary>
	<brief_title>Local Anesthesia Radial Catheterization</brief_title>
	<detailed_description>A total 444 consecutive patient , refer elective coronary angiography 1st Cardiology Department cathlab , suspicion coronary artery disease ( CAD ) enrol study . Exclusion criterion acute coronary syndrome , previous ipsilateral transradial approach , Raynaud 's syndrome , abnormal renal function without need hemodialysis , know history sensitivity local anesthetic , non-palpable radial pulse , abnormal Barbeau 's test patient 's refusal . Baseline clinical , demographic procedural data study population record . Participants randomly assign either EMLA ( AO ) lidocaine group ( LA ) , randomization table . Primary end-point : perception radial pain assess artery puncture 30 minute sheath removal . Secondary end-point : The number puncture attempt , total time require successful sheath insertion , occurrence radial artery spasm also document group Participants observe 4 hour post angiography development local complication side effect .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<criteria>referral elective diagnostic coronary angiography acute coronary syndrome , previous ipsilateral transradial approach , Raynaud 's syndrome , abnormal renal function without need hemodialysis , know history sensitivity local anesthetic , nonpalpable radial pulse , abnormal Barbeau 's test patient 's refusal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>